From new reconstructional technologies, new hope for children with bone tumours
The two main bone sarcomas (osteosarcoma and Ewing’s sarcoma) are rare diseases (estimated at 100-120 new cases per year) which hit the young, with children accounting for over half of all cases. Once fatal, the prognosis for these diseases has improved hugely over the last 50 years and around 70% of patients now have the same life expectancy rates as their peers. Skeletal surgery has evolved at the same time, enabling amputations to be avoided, and in the last 20 years innovative surgical strategies have widened the range of reconstruction options and opened the door to exciting prospects of psycho-physical recovery for children with bone cancer.
Istituto Rizzoli’s experience is an area of excellence for Bologna in Italian, European and global terms.